Celltrion Leads Xolair Biosimilar Race With US FDA Application

The Application Was Based On The Totality of Evidence From Several Trials

 
• By Urtė Fultinavičiūtė
  
Celltrion website logo
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products